ÐÓ°ÉÊÓÆµ

Skip to main content

release

T-cells
Fighting breast cancer with nanotech, immunotherapy 
ÐÓ°ÉÊÓÆµ researcher takes aim at hard-to-treat metastatic cancers by using new method to unlock ‘cold tumors’ for successful treatment A team of scientists led by aresearcher at the ÐÓ°ÉÊÓÆµ School of Medicine is making strides to fight deadly…
immunotherapy
Powerful push to use AI for cancer immunotherapy
ÐÓ°ÉÊÓÆµ works with NYU and pharmaceutical companies Bristol Myers Squibb, AstraZeneca to validate imaging-based solutions for predicting response to therapy for lung cancer patients For artificial intelligence (AI) tools being developed at ÐÓ°ÉÊÓÆµ to…
sunscreen
Studying how skin cancer starts
ÐÓ°ÉÊÓÆµ chemists measure ‘picosecond’ speed of pre-cancer cells’ lesions that form on DNA when exposed to sunlight; could lead to more effective prevention Luis Ortiz-Rodríguez grew up on the beaches of Puerto Rico—surfing, swimming and running in the hot sand—and swears he had never…
data_abstract
Mathematicians forecast COVID-19 spread
Researchers from ÐÓ°ÉÊÓÆµ, University of Akron, develop algorithm used by Cuyahoga County to predict fluctuations in number of COVID-19 cases A highly accurate forecast tool created by mathematicians from ÐÓ°ÉÊÓÆµ and The University of Akron is being used by…
Stordalan_1
Studying climate change at high speed
ÐÓ°ÉÊÓÆµ collaborates with 13 universities as part of National Science Foundation global project to understand interaction of climate and ecosystems ÐÓ°ÉÊÓÆµ is one among 14 universities from around the globe that have collectively been awarded $12.5…
Cancer
Mosaic ImmunoEngineering Inc. signs license-option to advance novel immunotherapy to treat cancer and infectious diseases
Agreement with CWRU Technology Transfer Office and Dartmouth College Mosaic ImmunoEngineering Inc., a private biotechnology company based in Novato, California, has signed a two-year option agreement with ÐÓ°ÉÊÓÆµ and Dartmouth College, granting the company the exclusive…
petri-dish-feat
Luminary Therapeutics and ÐÓ°ÉÊÓÆµ enter formal collaboration for development of BAFF CAR
Luminary Therapeutics (Luminary Tx) and ÐÓ°ÉÊÓÆµ have entered into a formal collaboration agreement that includes an option for Luminary to exclusively license a novel BAFF target for use in CAR-T (chimeric antigen receptor T cells) constructs. The BAFF target was discovered…
metalens_illustration
A new lens on the world
ÐÓ°ÉÊÓÆµ scientists, collaborators at Harvard and Italian university Unical, aim to ‘revolutionize optics’ by combining nanostructured metasurfaces with liquid crystal technology For more than 500 years, humans have mastered the art of refracting light by shaping glass into lenses,…
law-school
ÐÓ°ÉÊÓÆµ School of Law offers new flexible-start option, accepts GRE
The ÐÓ°ÉÊÓÆµ School of Law will be among the few law schools in the country to offer first-year law students the flexible option to start in January, Co-Deans Jessica Berg and Michael Scharf announced. For the first time, the law school is also now accepting GRE scores from…
robotics
Taking the next step in biorobotics
ÐÓ°ÉÊÓÆµ roboticist Roger Quinn, neuroscientist Hillel Chiel to lead $8 million, five-year National Science Foundation NeuroNex Network project seeking next level of control of neuromechanical systems A pair of longtime collaborators and biorobotic pioneers at ÐÓ°ÉÊÓÆµâ€¦